Bright future for Fine Organic Industries: HDFC Securities
Chemical

Bright future for Fine Organic Industries: HDFC Securities

FOIL has completed most of its long-term (over 1 year) contracts, and is now only getting into short-term (~3 months) contracts.

  • By ICN Bureau | October 06, 2021

HDFC Securities recommends Fine Organic Industries Ltd (FOIL) due to the company’s constant focus on R&D, diversified product portfolio, capacity-led expansion growth opportunity, and leadership in oleo-chemical based additives in the domestic and global markets with a loyal customer base.

HDFC Securities expects FOIL's PAT to grow at a 42% CAGR over FY22-24E, led by a 37% CAGR in EBITDA. In the absence of any major Capex over the next two years, the RoCE would expand from 19% in FY22E to 28% in FY24E. The constant focus on R&D and availability of capacity will enable the company to remain competitive and expand its customer base. Given the capacity expansion-led growth, FOIL's capability to generate 20%+ returns on reinvested profits, and unique business model with high entry barriers.

Margins on an upward trend from here

High input costs lead to a drop in margins: FOIL's margins have been under pressure for over a year, owing to, (1) the volatile and high raw material prices, (2) high freight cost impacted by global supply chain disruption. The rise in prices of vegetable oils, which are the key raw material, is attributable to many factors such as shifting of the demand from food basket to fuel basket, increase in buying by China, labour issues due to lockdowns in Indonesia and Malaysia, climatical impact on soya producing areas and imposing of import duties on palm oil in India, which is the world's largest importer of it.

Reduction in the volatility of raw material prices: Raw material prices continue to be high currently, but aren't as volatile, owing to (1) reduction in import duty on vegetable oils by the government of India, (2) reduction in the ceiling rate of its crude palm oil (CPO) export levy by Indonesia, and (3) reduction in excessive buying done by China.

Steps taken by the company to protect its margins: FOIL has completed most of its long-term (over 1 year) contracts, and is now only getting into short-term (~3 months) contracts. It has been successful in renegotiating contracts with its customers to take the raw material price hike. In order to reduce the blow of higher freights costs, the company has introduced a new system of FOB pricing where customers are charged freight prevalent at the time of shipment.

HDFC Securities expects these changes along with better plant utilisation to drive the EBITDA margin by 542bps from 18% in FY21 to 23% in FY24E.

Growth to be backed by capacity expansion

The remaining portion of the 10ktpa capacity dedicated to food additives at Patalganga will get commissioned by FY22 end. With the addition of this facility, the total capacity of the company will reach 111.3ktpa. All the plants are expected to reach optimum utilisation by FY24E.

FOIL has acquired a 45% stake in Fine Organic Industries (Thailand) Co. Ltd., which is a JV, formed to manufacture food additives in Thailand. The company plans to initially use up the existing capacity at the plant with minor changes in the plant and manufacture a few products immediately. Once travel resumes, the company will send its project team to evaluate opportunities there and come up with a Capex plan, post which the company shall augment its product and process portfolio.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.